Pyxis Oncology, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -29.1% | -29.1% | -27.1% |
| FY2022 | -75.1% | -75.1% | -57.1% |
| FY2023 | -58.7% | -58.7% | -42.5% |
| FY2024 | -64.0% | -64.0% | -49.2% |
| FY2025 | -149.1% | -149.1% | -87.0% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -29.1% | -29.1% | -27.1% |
| FY2022 | -75.1% | -75.1% | -57.1% |
| FY2023 | -58.7% | -58.7% | -42.5% |
| FY2024 | -64.0% | -64.0% | -49.2% |
| FY2025 | -149.1% | -149.1% | -87.0% |